Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Keryx plans pre-IND meeting with FDA for KRX-123

Dec. 19, 2002

Nippon Shinyaku acquires rights to Trisenox in certain Asian countries

Dec. 19, 2002

Zevalin and high-dose BEAM chemotherapy in non-Hodgkin's lymphoma

Dec. 19, 2002

Antitumor effects of CI-1033 in human breast cancer cells

Dec. 18, 2002

GW-572016 effective in model of tamoxifen-resistant breast cancer

Dec. 18, 2002

Targeting the uPA system with antibodies as a new approach to cancer therapy

Dec. 18, 2002

Cell-permeable MOE RNA oligonucleotide with telomerase-inhibitory effects

Dec. 18, 2002

OGX-011 enters clinical testing

Dec. 18, 2002

Oral formulation of Triapine demonstrates oral bioavailability

Dec. 18, 2002

Antitumor compounds discovered at Zenyaku Kogyo

Dec. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...